The PE Ratio as of June 2026 (TTM) for JW (Cayman) Therapeutics Co. Ltd (JWCTF) is -1.19

According to JW (Cayman) Therapeutics Co. Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -1.19. This represents a change of 59.69% compared to the average of -0.75 of the last 4 quarters.

JW (Cayman) Therapeutics Co. Ltd (JWCTF) Historical PE Ratio (quarterly & annually)

How has JWCTF PE Ratio performed in the past?

The mean historical PE Ratio of JW (Cayman) Therapeutics Co. Ltd over the last ten years is -5.27. The current -1.19 PE Ratio has changed 2.16% with respect to the historical average. Over the past ten years (40 quarters), JWCTF's PE Ratio was at its highest in in the December 2024 quarter at -0.36. The PE Ratio was at its lowest in in the January 2018 quarter at -24.11.

JW (Cayman) Therapeutics Co. Ltd (JWCTF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of JW (Cayman) Therapeutics Co. Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

JW (Cayman) Therapeutics Co. Ltd (JWCTF) Average PE Ratio

How has JWCTF PE Ratio performed in the past?

The current PE Ratio of JW (Cayman) Therapeutics Co. Ltd (JWCTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

JW (Cayman) Therapeutics Co. Ltd (JWCTF) PE Ratio vs. Peers

How is JWCTF’s PE Ratio compared to its peers?

JW (Cayman) Therapeutics Co. Ltd’s PE Ratio is greater than Molecular Partners AG (-2.02), greater than Santhera Pharmaceuticals Holding AG (-4.10), greater than Brii Biosciences Limited (-2.83), greater than Genfit S.A. (-5.49), greater than Innate Pharma S.A. (-2.91), greater than NervGen Pharma Corp. (-8.54), greater than NDT Pharmaceuticals Inc. (-3395.40), less than Botanix Pharmaceuticals Limited (-0.51), greater than Scancell Holdings plc (-38.48), less than YourWay Cannabis Brands Inc. (-0.00),

Build a custom stock screener for JW (Cayman) Therapeutics Co. Ltd (JWCTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like JW (Cayman) Therapeutics Co. Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

JW (Cayman) Therapeutics Co. Ltd (JWCTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like JW (Cayman) Therapeutics Co. Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.